Fundz

Elektrofi Raises $40 Million Financing To Establish Gmp Manufacturing Capabilities For Upcoming Clinical Studies And Expand Development Pipeline

PRIVATEJun 13, 2022

Amount Raised

$40 Million

Round Type

Funding Round

BostonBiotechnology

Description

Elektrofi, a Boston-based biotechnology company focused on drug formulation and delivery innovations, today announced the completion of a $40 million Series B financing round. A portion of the proceeds will be used to establish a centralized GMP manufacturing line in support of multiple upcoming clinical trials. The company will also plan to double headcount over the next 12-18 months to accelerate development across a growing pipeline of licensed programs with leading pharma and biotech.

Quick answer

Elektrofi raised $40 Million in a Funding Round round, dated June 13, 2022. Elektrofi is based in Boston, Massachusetts, United States.

How much did Elektrofi raise?
Elektrofi raised $40 Million in a Funding Round round on June 13, 2022.
What does Elektrofi do?
Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from..
Where is Elektrofi based and how big is it?
Elektrofi is based in Boston, Massachusetts, United States. Fundz records about 99 employees.
Who are the decision-makers at Elektrofi?
Fundz holds 1 contact at Elektrofi. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Elektrofi that raised within 45 days of this round, from Fundz verified event records.

  • Animol raised $34M (Series B) on July 28, 2022.
  • Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
  • Vicinitas Therapeutics raised $65M (Series A) on July 28, 2022.
  • SEngine Precision Medicine, Inc. raised an undisclosed amount (Series A) on July 28, 2022.
  • Suvera raised $6.5M (Funding Round) on July 28, 2022.
  • Core Biogenesis raised $11M (Funding Round) on July 28, 2022.

Who to call at Elektrofi, and when

A new round usually means Elektrofi is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elektrofi raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elektrofi, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elektrofi. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elektrofi

Location

25 DRYDOCK AVENUE, SECOND FLOOR

Boston, Massachusetts, United States

About

Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, Hypercon™, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are headquartered in Boston and innovate globally.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elektrofi raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Elektrofi's next move

See what Strategic adds

Elektrofi raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.